Vestmark Advisory Solutions, Inc. Astrazeneca PLC Transaction History

Vestmark Advisory Solutions, Inc.

$2.63 Billion
Q4 2024

A detailed history of Vestmark Advisory Solutions, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 30,582 shares of AZN stock, worth $2.29 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

30,582

Previous 24,353 25.58%

Holding current value

$2.29 Million

Previous $1.9 Million 5.59%

% of portfolio

0.08%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$63.2 - $79.58 $393,672 - $495,703	6,229 Added 25.58%	30,582 $2 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $36,648 - $41,882	478 Added 2.0%	24,353 $1.9 Million
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $33,137 - $40,091	496 Added 2.12%	23,875 $1.86 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $188,704 - $215,110	-3,092 Reduced 11.68%	23,379 $1.58 Million
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $131,083 - $146,735	2,118 Added 8.7%	26,471 $1.78 Million
Q3 2023 Nov 06, 2023	SELL	$64.85 - $71.7 $2.2 Million - $2.44 Million	-33,966 Reduced 58.24%	24,353 $1.65 Million
Q2 2023 Aug 07, 2023	SELL	$69.91 - $75.81 $481,400 - $522,027	-6,886 Reduced 10.56%	58,319 $4.17 Million
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $36,311 - $41,170	-575 Reduced 0.87%	65,205 $4.53 Million
Q4 2022 Jan 20, 2023	SELL	$54.21 - $70.44 $86,302 - $112,140	-1,592 Reduced 2.36%	65,780 $0
Q3 2022 Nov 03, 2022	BUY	$53.02 - $135.75 $386,515 - $989,617	7,290 Added 12.13%	67,372 $3.69 Million
Q2 2022 Aug 04, 2022	BUY	$59.26 - $71.14 $1.04 Million - $1.25 Million	17,626 Added 41.52%	60,082 $3.97 Million
Q1 2022 Apr 27, 2022	BUY	$55.72 - $67.12 $155,681 - $187,533	2,794 Added 7.04%	42,456 $2.82 Million
Q4 2021 Jan 31, 2022	SELL	$54.02 - $63.83 $139,641 - $165,000	-2,585 Reduced 6.12%	39,662 $2.31 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $152,234 - $166,564	-2,740 Reduced 6.09%	42,247 $2.54 Million
Q2 2021 Aug 09, 2021	BUY	$48.42 - $60.18 $294,732 - $366,315	6,087 Added 15.65%	44,987 $2.7 Million
Q1 2021 May 10, 2021	BUY	$47.16 - $54.44 $120,682 - $139,311	2,559 Added 7.04%	38,900 $1.93 Million
Q4 2020 Feb 04, 2021	BUY	$48.52 - $58.02 $102,037 - $122,016	2,103 Added 6.14%	36,341 $1.82 Million
Q3 2020 Oct 19, 2020	BUY	$53.07 - $61.1 $50,628 - $58,289	954 Added 2.87%	34,238 $1.88 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $218,301 - $280,145	-5,065 Reduced 13.21%	33,284 $1.76 Million
Q1 2020 May 06, 2020	SELL	$37.79 - $51.33 $28,191 - $38,292	-746 Reduced 1.91%	38,349 $1.71 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $111,967 - $133,063	-2,637 Reduced 6.32%	39,095 $1.95 Million
Q3 2019 Nov 05, 2019	SELL	$40.12 - $45.47 $52,035 - $58,974	-1,297 Reduced 3.01%	41,732 $1.86 Million
Q2 2019 Aug 20, 2019	BUY	$37.28 - $41.68 $28,705 - $32,093	770 Added 1.82%	43,029 $1.78 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $1.5 Million - $1.82 Million	42,259 New	42,259 $1.71 Million

Others Institutions Holding AZN

# of Institutions

1,353

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $232B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account

Vestmark Advisory Solutions, Inc. Astrazeneca PLC Transaction History